msnho.com

Report Overview:

The Global Fitness App Market achieved a valuation of $5.87 Billion in 2022 and is anticipated to exceed $21.06 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 17.3% during the forecast period from 2024 to 2032.

Key Market Players:

RunKeeper, Google LLC, MyFitnessPal, Sworkit, Runtastic (Adidas), JEFIT Workout Tracker, Nike Run Club.

Report Overview:

The Global Hearable Devices Market achieved a valuation of $20.82 Billion in 2022 and is anticipated to exceed $43.34 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 9.6% during the forecast period from 2024 to 2032.

Key Market Players:

Samsung Electronics Co., Ltd. (South Korea), Apple Inc. (US), Sony Corporation (Japan), Sennheiser Electronics GmBH, co. kg (Germany), and GN Store Nord A/S (Denmark).

Report Overview:

The Global Big Data Analytics in Healthcare Market achieved a valuation of $25.76 Billion in 2022 and is anticipated to exceed $195.17 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 28.8% during the forecast period from 2024 to 2032.

Key Market Players:

Report Overview:

The Global Medical Sensors Market achieved a valuation of $1.10 Billion in 2022 and is anticipated to exceed $2.39 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 10.2% during the forecast period from 2024 to 2032.

Key Market Players:

Medtronic (Ireland), TE Connectivity (Switzerland), Analog Devices (US), ST Microelectronics (Switzerland), and Texas Instruments (US).

Report Overview:

The Global Ventilator Market achieved a valuation of $6.41 Billion in 2022 and is anticipated to exceed $10.87 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 6.8% during the forecast period from 2024 to 2032.

Key Market Players:

Report Overview:

The Global Healthcare Predictive Analytics Market achieved a valuation of $25.38 Billion in 2022 and is anticipated to exceed $170.76 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 26.9% during the forecast period from 2024 to 2032.

Key Market Players:

Cerner Corporation, Information Builders Inc., International Business Machines Corporation (IBM), Oracle Corporation, Health Catalyst

Report Overview:

The Global Hydroxychloroquine Market achieved a valuation of $949.65 Million in 2022 and is anticipated to exceed $1446.43 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 5.4% during the forecast period from 2024 to 2032.

Key Market Players:

Sanofi, Amneal Pharmaceuticals, Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Novartis AG, Zydus Cadila, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Lupin Limited, Prasco Laboratories

Report Overview:

The Global Diagnostic Biomarkers Market achieved a valuation of $50.36 Billion in 2022 and is anticipated to exceed $123.84 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 11.9% during the forecast period from 2024 to 2032.

Key Market Players:

Biocrates Life Sciences AG, Augurex Life Sciences Corp., Biomedical Corp., Target Discovery, Banyan Biomarkers, Inc., Astute Medical, Inc., Axela Inc.

Report Overview:

The Global Creatinine Test Market achieved a valuation of $1154.20 Million in 2022 and is anticipated to exceed $3783.92 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 16% during the forecast period from 2024 to 2032.

Key Market Players:

BioAssay Systems, Abcam plc, Arbor Assays, Thermo Fisher Scientific, Randox Laboratories Ltd., Sentinel CH. SpA, DiaSys Diagnostic Systems GmbH, MedTest Holdings, Inc. (Pointe Scientific, Inc.), Abbexa Ltd., and General Atomics, Inc. (Diazyme Laboratories, Inc.).

Report Overview:

The Global Deoxyribonucleic Acid (DNA) Vaccines Market achieved a valuation of $4.28 Billion in 2022 and is anticipated to exceed $7.41 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 7.1% during the forecast period from 2024 to 2032.

Key Market Players:

Inovio Biomedical Corp, Merck & Co., Mitsubishi Tanabe, Dendreon Corporation, ASTELLAS PHARMA, Dynavax Technologies, Sanofi, Tekmira Pharmaceuticals GlaxoSmithKline Corp, Protein Sciences Corp.among others.